Barbara M. Ryan YOU? Author Swipe

Last 10y

Open Invitation to Help Curate This Field & Enhance Impact .ORG

<i>Ex vivo</i> spectroscopic characterisation of the biological activity of pancreatic cyst fluid Open

Outmane Bouzerda, Laura Kane, Gregory S. Mellotte, Barbara M. Ryan, Stephen G. Maher , et al. · 2025

Chemistry Medicine Biology

Pancreatic cystic lesions (PCLs) are fluid-filled sacs often identified incidentally during abdominal imaging for unrelated pancreatic indications.

P552 Clinical factors associated with ustekinumab therapy persistence in a refractory Crohn’s disease cohort Open

R Corcoran, N Breslin, Barbara M. Ryan, A O’Connor, S O'Donnell , et al. · 2024

Medicine Biology Engineering

Background Ustekinumab (UST) is a monoclonal antibody that binds to the p40 subunit shared by pro-inflammatory interleukins 12 and 23. UST has demonstrated efficacy for the induction and maintenance of remission in patients with Crohn’s di…

P041 Assessment of Serum Biomarkers associated with Vedolizumab Therapy Response in Inflammatory Bowel Disease Open

J E A O'Connell, Ruth Argue, Mary Dunne, Fiona O’Connell, Niall Breslin , et al. · 2024

Medicine

Background Vedolizumab (VDZ) is an anti α4β7-integrin inflammatory bowel disease (IBD) therapy postulated to reduce immune cell trafficking to the intestine. A significant proportion of patients fail to respond to VDZ. We aimed to assess t…

UK and Ireland Joint Advisory Group (JAG) consensus statements for training and certification in diagnostic endoscopic ultrasound (EUS) Open

Tareq El Menabawey, Raymond McCrudden, Dushyant Shetty, Andrew D. Hopper, Matthew T. Huggett , et al. · 2023

Medicine Psychology Computer science

Background and aims International endoscopy societies vary in their approach for credentialing individuals in endoscopic ultrasound (EUS) to enable independent practice; however, there is no consensus in this or its implementation. In 2019…

Supplementary Material S5 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine

Complete list of extracted data fields

Supplementary Material S1 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine

PRISMA 2020 checklist

Supplementary Material S8 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine Biology

Figure S8 panels A-E

Data from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine Biology

Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate below 5%. Carbohydrate antigen 19-9 (CA19-9) is the most commonly used blood-based biomarker for PDAC in current clinical practice, despite having been shown repeatedly to …

Supplementary Material S2 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine

PRISMA flow chart

Supplementary Material S6 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine

QUADAS-2

Supplementary Material S7 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine

Complete extracted dataset

Supplementary Material S2 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine

PRISMA flow chart

Supplementary Material S4 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine Biology

Inclusion exclusion criteria

Supplementary Material S3 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine

Individualised search strategy

Supplementary Material S4 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine Mathematics

Inclusion exclusion criteria

Supplementary Material S5 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine

Complete list of extracted data fields

Supplementary Material S1 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine Biology

PRISMA 2020 checklist

Data from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine Biology

Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate below 5%. Carbohydrate antigen 19-9 (CA19-9) is the most commonly used blood-based biomarker for PDAC in current clinical practice, despite having been shown repeatedly to …

Supplementary Material S6 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine

QUADAS-2

Supplementary Material S3 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine Biology

Individualised search strategy

Supplementary Material S7 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine Mathematics

Complete extracted dataset

Supplementary Material S8 from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Open

Laura Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O’Connell , et al. · 2023

Medicine

Figure S8 panels A-E

P165 Vitamin D deficiency is associated with poor sleep quality in patients with Crohn’s disease Open

Christopher Walker, W Stacey, K M Ramkalawan, Y Kafienah, R Connaughton , et al. · 2023

Medicine

Background Sleep disturbances affect 40-50% of patients with Crohn’s Disease and are associated with disease flares. Symptoms, treatment side effects and pro-inflammatory status have been shown to have an effect on sleep quality and durati…

P865 Anxiety and Depression is Associated with Poor Sleep Quality in patients with Inflammatory Bowel Disease (IBD) Open

R Connaughton, Y Kafienah, K Ramkalawan, W Stacey, Christopher Walker , et al. · 2023

Medicine Economics

Background Sleep disturbances affect 40-50% of patients with IBD and are associated with disease flares. Symptoms, treatment side effects and pro-inflammatory status have been shown to have an effect on sleep quality and duration. Anxiety …

P298 Risk factors for the progression of non-alcoholic fatty liver disease in people with inflammatory bowel disease Open

Christopher Walker, M Dempsey, R Connaughton, A Carroll, N Breslin , et al. · 2023

Medicine

Background Non-alcohol fatty liver disease (NAFLD) is one of the most common liver disorders, and occurs more frequently in people with inflammatory bowel disease (IBD). Previous research suggests that increased age, BMI, and IBD duration,…

P172 Metabolic disorders with non-alcoholic fatty liver disease in people with inflammatory bowel disease Open

Christopher Walker, E Stapleton, M Dempsey, A Carroll, R Connaughton , et al. · 2023

Medicine Physics

Background Globally rising rates of obesity and consequent metabolic diseases have been reflected in the inflammatory bowel disease (IBD) population. Non-alcohol fatty liver disease (NAFLD) is a common liver disorder associated with obesit…

Oral infliximab nanomedicines for targeted treatment of inflammatory bowel diseases Open

Lauren J. Mohan, Jacqueline S. Daly, Barbara M. Ryan, Zebunnissa Ramtoola · 2023

Medicine

Results from this study show that NP particle size can be used to differentially target and treat the inflamed intestinal barrier. Oral INF nanomedicines of modulated size present a novel strategy for the local, targeted treatment of IBD.

Creating related items for first view…

Fetching topic information...